Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
$658M |
| 2 |
Tesla
TSLA
|
$573M |
| 3 |
Bank of America
BAC
|
$480M |
| 4 |
Amazon
AMZN
|
$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$395M |
| 3 |
Eli Lilly
LLY
|
$364M |
| 4 |
CME Group
CME
|
$316M |
| 5 |
T-Mobile US
TMUS
|
$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Lantronix
LTRX
$185M
| $41K | ﹤0.01% |
16,460
+1,245
| +8% | +$3.1K |
|
3627
Lightwave Logic
LWLG
$423M
| $39.6K | ﹤0.01% |
38,665
-2,777
| -7% | -$2.85K |
|
|
QIPT
3628
Quipt Home Medical
QIPT
$113M
| $39.6K | ﹤0.01% |
16,981
-678
| -4% | -$1.58K |
|
3629
Mersana Therapeutics
MRSN
$34M
| $39.5K | ﹤0.01% |
4,595
+2,400
| +109% | +$20.7K |
|
3630
Atossa Therapeutics
ATOS
$102M
| $39.5K | ﹤0.01% |
58,669
-1,675
| -3% | -$1.13K |
|
3631
Immunic
IMUX
$75.1M
| $38.6K | ﹤0.01% |
35,409
-1,402
| -4% | -$1.53K |
|
3632
1stdibs.com
DIBS
$100M
| $35.9K | ﹤0.01% |
11,805
-359
| -3% | -$1.09K |
|
3633
Zynex
ZYXI
$45.1M
| $34.9K | ﹤0.01% |
15,868
-4,888
| -24% | -$10.8K |
|
3634
Larimar Therapeutics
LRMR
$337M
| $34.6K | ﹤0.01% |
16,112
-148
| -0.9% | -$318 |
|
3635
Denison Mines
DNN
$2.11B
| $34.5K | ﹤0.01% |
26,543
+31
| +0.1% | +$40 |
|
3636
CureVac
CVAC
$1.21B
| $34.3K | ﹤0.01% |
12,376
+836
| +7% | +$2.32K |
|
3637
Verrica Pharmaceuticals
VRCA
$48.3M
| $32.9K | ﹤0.01% |
7,439
+2,926
| +65% | +$12.9K |
|
3638
Nerdy
NRDY
$163M
| $32.3K | ﹤0.01% |
22,748
-1,131
| -5% | -$1.61K |
|
3639
Veru
VERU
$49.4M
| $30.4K | ﹤0.01% |
6,196
-282
| -4% | -$1.38K |
|
3640
Paysign
PAYS
$286M
| $30.2K | ﹤0.01% |
14,226
-599
| -4% | -$1.27K |
|
3641
Rekor Systems
REKR
$138M
| $29.9K | ﹤0.01% |
33,748
-1,143
| -3% | -$1.01K |
|
3642
Prime Medicine
PRME
$663M
| $29.5K | ﹤0.01% |
14,836
-235
| -2% | -$468 |
|
3643
Vuzix
VUZI
$188M
| $29K | ﹤0.01% |
14,235
-5,525
| -28% | -$11.3K |
|
3644
TScan Therapeutics
TCRX
$108M
| $28.4K | ﹤0.01% |
20,590
-38
| -0.2% | -$52 |
|
3645
ProKidney
PROK
$304M
| $28.3K | ﹤0.01% |
32,258
+135
| +0.4% | +$118 |
|
3646
Traeger
COOK
$200M
| $26.5K | ﹤0.01% |
15,772
+5,570
| +55% | +$9.36K |
|
3647
Lineage Cell Therapeutics
LCTX
$279M
| $26.2K | ﹤0.01% |
58,038
-3,747
| -6% | -$1.69K |
|
3648
Forge Global Holdings
FRGE
$235M
| $25.8K | ﹤0.01% |
3,063
-120
| -4% | -$1.01K |
|
3649
Applied Therapeutics
APLT
$68.2M
| $25K | ﹤0.01% |
51,098
-2,401
| -4% | -$1.17K |
|
3650
Pyxis Oncology
PYXS
$118M
| $24.3K | ﹤0.01% |
24,805
-561
| -2% | -$550 |
|